Hospital-level Variation in the Management of Blood Pressure and Low-density Lipoprotein in the Outpatient Hypertensives in China-a Cross Sectional Study

• Conditions: Hypertension; Hyperlipidemia
• Interventions: Other: continuing medical education program

• Registration Number: NCT03862183
• Lead Sponsor: Huashan Hospital

Brief Summary

To investigate the proportion, medication use and control rate of metabolic abnormalities such as dyslipidemia in outpatients with hypertension in different levels of hospitals in China. To investigate the gap between guidelines and clinical practices, and analyze the cause. we also set up a continuing medical education program to narrow the gap and the effect of the program will be estimated.

Detailed Description

Not available

Study Timeline

• Study Start: 2017-07-01
• Status Verified: 2019-03
• Study First Submitted: 2019-03-02
• Study First Submitted QC: 2019-03-02
• Last Update Submitted: 2019-03-02
• Study First Posted: 2019-03-05
• Last Update Posted: 2019-03-05
• Primary Completion: 2020-12-30
• Study Completion: 2020-12-30

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 21000

Inclusion Criteria

1. Outpatients from departments of Cardiology, Endocrinology, Nephrology, Neurology, Geriatrics or General Internal Medicine.
2. Diagnosed as hypertension. Diagnostic criteria: 1)The office BP measured at the day of visit and at least one time before that day were above the cut-off values ( ≥140 mmHg SBP and/or ≥90 mmHg DBP); 2)for patients with normal BP at the day of visit, they should have already been given pre-treatment with antihypertensive drugs ≥ 2 weeks.
3. Voluntary participation.

Exclusion Criteria

1. Patients aged< 18 years old.
2. Patients without a definite diagnosis of hypertension（for instance, if the patient has been taking antihypertensive drugs irregularly, it is difficult to confirm the diagnosis of hypertension）.
3. Patients with a definite diagnosis of secondary hypertension.
4. Patients are diagnosed dyslipidemia with clear cause, such as nephrotic syndrome, severe hypothyroidism, terminal stage of malignancy, etc.
5. Patients are diagnosed end-stage renal disease, hemodialysis, and peritoneal dialysis patients.
6. Patients diagnosed with mental abnormalities who are unable to complete the questionnaire.
7. Patients have once participated in this research during this study cycle（to avoid repeated participation）.

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
dyslipidemia in hypertension	continuing medical education program	-
hypertension	continuing medical education program	-

Primary Outcome Measures

Name	Time	Method
rate of blood pressure goal achievement	2017-2020	systolic blood pressure\<140mmHg and diastolic blood pressure\<90mmHg

Trial Locations

Locations (1)

Cardiology Department in Huashan Hospital; 🇨🇳 Shanghai, Shanghai, China